during the rapidly evolving area of oncology exploration, correct and productive mutation screening is vital for building qualified therapies. The KRAS solutions System performs a pivotal job Within this landscape by providing thorough solutions for KRAS mutation profiling and Evaluation. KRAS mutations, located in close to ninety five% of RAS-asso